Comparing Real-World Effectiveness of Dulaglutide and Insulin as the First Injectable for Patients with Type 2 Diabetes: An Australian Single-Site Retrospective Chart Review
Crossref DOI link: https://doi.org/10.1007/s13300-021-01184-x
Published Online: 2021-11-30
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Houssarini, Jared A. http://orcid.org/0000-0003-0237-1764
Brnabic, Alan J. M.
Obaid, Marwan
Text and Data Mining valid from 2021-11-30
Version of Record valid from 2021-11-30
Article History
Received: 14 September 2021
Accepted: 19 November 2021
First Online: 30 November 2021